An observational study in Sleep Apnea Syndrome, sponsored by Centre Hospitalier Universitaire Saint Pierre. Terminated. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2015-03-10.
Sponsored by Centre Hospitalier Universitaire Saint Pierre · Observational
Sleep apnea syndrome (OSA) frequently occurs in obese population undergoing bariatric surgery. There is a need for alternative screening tools for sleep apnea detection in the pre-operative period. The investigators would like to compare ApneaLink and complete polysomnography in this population.
OSA can occur in up to 78% of patients undergoing bariatric surgery(1). Moderate to severe case will benefit from CPAP therapy, that can help avoiding post-operative complications(2).
In this population, the investigators propose complete attended in-hospital polysomnography (PSG)in patients with a clinical high probability of OSA.
According to obesity epidemics (3), waiting list for PSG in sleep labs is every day longer.
The investigators want to assess sensitivity and specificity of a new portable screening tool, ApneaLink, to detect OSA in a bariatric population.
Design:
monocentric and prospective study
Methods:
Patients:
Measurements
1,422 studies on the registry are indexed under Apnea; 159 are open to participants now.
This study's enrollment of 9 is below the median of 106 across 386 observational studies indexed under Apnea.
Browse Apnea studies →Centre Hospitalier Universitaire Saint Pierre is the lead sponsor of 78 studies on the registry; 12 are open to participants now.
Counted across the registry records on this site, refreshed daily.
obese patients, > 18y old, in whom a bariatric surgery is planified and who have to undergo a polysomnography for OSA screening
Exclusion Criteria:
obese patients in whom a bariatric surgery is planified
Number of patients with correct diagnosis of OSA with ApneaLink. Therefore, we will compare apnea-hypopnea index measured with ApneaLink with apnea-hypopnea index measured during polysomnography.
Time frame: 2 weeks
No study locations are listed for this record.
This study is terminated, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire Saint Pierre